Mylan is a global pharmaceutical company that specializes in manufacturing and distributing generic, branded and over-the-counter (OTC) products in various therapeutic areas.
Founded in 1961 in West Virginia
Initially started as a pharmaceutical distributor
In 1965, Mylan began manufacturing its own products and entered into the generic drug market
Acquired several companies including Matrix Laboratories, Abbott Laboratories' non-U.S. developed markets specialty and branded generics business, and the dermatology portfolio of Renaissance Acquisition Holdings, LLC
Currently, Mylan operates in over 165 countries and has a portfolio of more than 7,500 products
One of the largest generic drug manufacturers in the world
A global leader in generic and biosimilar pharmaceuticals
A healthcare supply chain management company that distributes pharmaceuticals and medical products
An epinephrine auto-injector that provides emergency treatment for anaphylaxis
A widely used antibiotic to treat various bacterial infections
A medication used to treat high blood pressure and heart failure
Mylan focuses on manufacturing and distributing generic, branded and over-the-counter (OTC) products in various therapeutic areas.
Mylan currently operates in over 165 countries.
EpiPen is an epinephrine auto-injector that is used in emergency situations to treat anaphylaxis, which is a severe and potentially life-threatening allergic reaction.
Generic drugs are identical or bioequivalent to brand-name drugs in dosage form, safety, strength, route of administration, quality, and intended use, whereas branded drugs are developed and marketed by the original manufacturer.
Yes, Mylan offers over-the-counter (OTC) products in various therapeutic areas.